Like the ball whirling around a casino roulette wheel, COVID-19 sent the US Joint Fluid Market players bouncing and spinning off widely, with some landing the year as winners, and others not so much.
Among the many topics covered in the comprehensive Q420/FY20 US Joint Fluid Market Recap* are:
- Complete US Joint Fluid Market Overview
- Companies' Financials, Revenues and Market Share
- All Key Competitors' Results
- Notable Q420 Segment Developments
Along with the impact of COVID-19, the US Joint Fluid Replacement market continued to see harsh competition among HA players looking to grow their footprint within key strategic territories &/or accounts. Also, as some looked to capture more market shares in the midst of the COVID-19 whirlwind, others are investing with purpose in R&D, placing stakes on diversification and growing the size of the HA market altogether. That said, while several manufacturers are developing ...
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module.
SmartTRAK kicked off 2021 with some exciting new product launches, including Arthroscopic Technologies; Deep Brain Stimulation; Pediatric Extremities, Trauma and Spine. For more information on how to receive a demo and subscribe, please click here.
